Real-World Evidence Leverage the newly appointed Senior VP of Real-World Evidence to position as a partner for outcomes research, post-market analytics, and value demonstrations to payers and providers.

Strategic Investment Target Fengate Capital’s platform investing interest to explore co-development or co-funding opportunities for expanded distribution, analytics services, and global deployment of value-driven healthcare programs.

Independent Analytics Highlight eMAX Health Research and Analytics as a differentiator for comparative effectiveness research and independent outcomes monitoring to support formulary decisions and rebates adjudication for payers.

Patient Access Position the Patient Access Center capabilities to healthcare plans and PBMs as a means to improve access to therapies, streamline prior authorization processes, and reduce time-to-treatment.

Turnkey Services Emphasize global turnkey professional services for implementing accountable care to attract health systems and large employers seeking end-to-end solutions for value-based care contracts.